• 1. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 2. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 3. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 4. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 5. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives 2(hydroxyphenyl)acetic acids
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylacetic acids 2(hydroxyphenyl)acetic acids

2-(4-Bromo-2-hydroxyphenyl)acetic acid: An Overview of a Promising Compound (CAS No. 1261497-72-6)

2-(4-Bromo-2-hydroxyphenyl)acetic acid (CAS No. 1261497-72-6) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as Bromohydroxyphenylacetic acid, is characterized by its unique structural features, which include a bromine atom and a hydroxyl group attached to a phenyl ring, along with an acetic acid moiety. These structural elements contribute to its diverse biological activities and potential therapeutic applications.

The chemical structure of 2-(4-Bromo-2-hydroxyphenyl)acetic acid is represented by the molecular formula C₉H₉BrO₃. The presence of the bromine atom and the hydroxyl group imparts specific chemical properties that make this compound an attractive candidate for various medicinal applications. The acetic acid group further enhances its solubility and reactivity, making it suitable for use in both in vitro and in vivo studies.

Recent research has focused on the potential of 2-(4-Bromo-2-hydroxyphenyl)acetic acid as an anti-inflammatory agent. Studies have shown that this compound exhibits significant anti-inflammatory activity by inhibiting the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). These findings suggest that 2-(4-Bromo-2-hydroxyphenyl)acetic acid could be a valuable candidate for the development of new anti-inflammatory drugs, particularly for conditions such as rheumatoid arthritis and inflammatory bowel disease.

In addition to its anti-inflammatory properties, 2-(4-Bromo-2-hydroxyphenyl)acetic acid has also been investigated for its potential as an anticancer agent. Preclinical studies have demonstrated that this compound can induce apoptosis in various cancer cell lines, including breast cancer, colon cancer, and leukemia cells. The mechanism of action involves the modulation of key signaling pathways such as the mitogen-activated protein kinase (MAPK) pathway and the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. These pathways are known to play crucial roles in cell proliferation, survival, and metastasis.

The pharmacokinetic properties of 2-(4-Bromo-2-hydroxyphenyl)acetic acid have also been studied to evaluate its suitability for drug development. Research has shown that this compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) properties. It is rapidly absorbed after oral administration and has a moderate half-life, which allows for sustained therapeutic effects. Furthermore, the compound shows low toxicity in animal models, making it a promising candidate for further clinical evaluation.

In the context of drug discovery and development, 2-(4-Bromo-2-hydroxyphenyl)acetic acid has been used as a lead compound for structure-activity relationship (SAR) studies. By modifying the chemical structure through synthetic chemistry techniques, researchers have identified several derivatives with enhanced biological activities and improved pharmacological profiles. These derivatives are currently being evaluated for their potential as novel therapeutic agents.

The safety profile of 2-(4-Bromo-2-hydroxyphenyl)acetic acid is another important aspect that has been extensively studied. Toxicological assessments have shown that this compound is well-tolerated at therapeutic doses and does not exhibit significant adverse effects on major organs such as the liver and kidneys. However, as with any new drug candidate, further safety studies are required to ensure its long-term safety and efficacy.

In conclusion, 2-(4-Bromo-2-hydroxyphenyl)acetic acid (CAS No. 1261497-72-6) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure confers multiple biological activities, including anti-inflammatory and anticancer properties. Ongoing research continues to explore its therapeutic potential and optimize its pharmacological profile for future clinical use.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)